Risk of ovarian hyperstimulation syndrome in women with malignancies undergoing treatment with long-acting gonadotropin-releasing hormone agonist after controlled ovarian hyperstimulation for fertility preservation: a systematic review (2023)
- Authors:
- Autor USP: NAVARRO, PAULA ANDREA DE ALBUQUERQUE SALLES - FMRP
- Unidade: FMRP
- DOI: 10.1177/26334941231196545
- Subjects: FERTILIDADE; HORMÔNIO LIBERADOR DE GONADOTROFINAS; NEOPLASIAS
- Keywords: Fertility preservation; Gonadotropin-releasing hormone; Ovulation induction; Ovarian hyperstimulation syndrome; Neoplasms
- Language: Inglês
- Imprenta:
- Source:
- Título: Therapeutic Advances in Reproductive Health
- ISSN: 2633-4941
- Volume/Número/Paginação/Ano: v. 17, art. 26334941231196545, p. 1-11, 2023
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
INGOLD, Caroline et al. Risk of ovarian hyperstimulation syndrome in women with malignancies undergoing treatment with long-acting gonadotropin-releasing hormone agonist after controlled ovarian hyperstimulation for fertility preservation: a systematic review. Therapeutic Advances in Reproductive Health, v. 17, p. 1-11, 2023Tradução . . Disponível em: https://doi.org/10.1177/26334941231196545. Acesso em: 21 jan. 2026. -
APA
Ingold, C., Navarro, P. A. de A. S., Oliveira, R. de, Barbosa, C. P., & Bedoschi, G. (2023). Risk of ovarian hyperstimulation syndrome in women with malignancies undergoing treatment with long-acting gonadotropin-releasing hormone agonist after controlled ovarian hyperstimulation for fertility preservation: a systematic review. Therapeutic Advances in Reproductive Health, 17, 1-11. doi:10.1177/26334941231196545 -
NLM
Ingold C, Navarro PA de AS, Oliveira R de, Barbosa CP, Bedoschi G. Risk of ovarian hyperstimulation syndrome in women with malignancies undergoing treatment with long-acting gonadotropin-releasing hormone agonist after controlled ovarian hyperstimulation for fertility preservation: a systematic review [Internet]. Therapeutic Advances in Reproductive Health. 2023 ; 17 1-11.[citado 2026 jan. 21 ] Available from: https://doi.org/10.1177/26334941231196545 -
Vancouver
Ingold C, Navarro PA de AS, Oliveira R de, Barbosa CP, Bedoschi G. Risk of ovarian hyperstimulation syndrome in women with malignancies undergoing treatment with long-acting gonadotropin-releasing hormone agonist after controlled ovarian hyperstimulation for fertility preservation: a systematic review [Internet]. Therapeutic Advances in Reproductive Health. 2023 ; 17 1-11.[citado 2026 jan. 21 ] Available from: https://doi.org/10.1177/26334941231196545 - Infertility associated to endometriosis [Editorial]: clarifying some important controversies
- Non invasive imaging of spindle of in vivo matured oocytes from infertile patients with endometriosis and controls
- Expressão do gene PTGS2 (COX2) em células do cumulus de pacientes inférteis com endometriose e controles submetidas à ICSI
- Comparative analysis of the spindle and chromosome configurations of in vitro-matured oocytes from patients with polycystic ovary syndromne and from controls: a pilot study
- Impact of hypophyseal suppression and controlled ovarian stimulation on anti-mullerian serum levels in patients with and without endometriosis submitted to ICSI
- Amenorreia primária
- Novel insights into the pathophysiology of chemotherapy-induced damage to the ovary
- Depressão em mulheres climatéricas: análise de mulheres atendidas ambulatorialmente em um hospital universitário no Maranhão
- Risk of contamination of gametes and embryos during cryopreservation and measures to prevent cross-contamination
- Uso clínico do hormônio antimülleriano em ginecologia
Informações sobre o DOI: 10.1177/26334941231196545 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003256620.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
